Free Trial

Lonza Group (LZAGY) Stock Forecast & Price Target

Lonza Group logo
$70.84 -0.25 (-0.35%)
As of 08/29/2025 03:50 PM Eastern

Lonza Group - Analysts' Recommendations and Stock Price Forecast (2025)

Consensus Rating

Sell
0
Hold
0
Buy
2

Based on 2 Wall Street analysts who have issued ratings for Lonza Group in the last 12 months, the stock has a consensus rating of "Strong Buy." Out of the 2 analysts, 2 have given a strong buy rating for LZAGY.

Consensus Price Target

N/A

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
Get the Latest News and Ratings for LZAGY and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Lonza Group and its competitors.

Sign Up
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

LZAGY Analyst Ratings Over Time

TypeCurrent Forecast
8/30/24 to 8/30/25
1 Month Ago
7/31/24 to 7/31/25
3 Months Ago
6/1/24 to 6/1/25
1 Year Ago
8/31/23 to 8/30/24
Strong Buy
2 Strong Buy rating(s)
2 Strong Buy rating(s)
3 Strong Buy rating(s)
1 Strong Buy rating(s)
Buy
0 Buy rating(s)
0 Buy rating(s)
0 Buy rating(s)
2 Buy rating(s)
Hold
0 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price TargetN/AN/AN/AN/A
Forecasted UpsideN/AN/AN/AN/A
Consensus Rating
Strong Buy
Strong Buy
Strong Buy
Buy

LZAGY Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

LZAGY Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Lonza Group Stock vs. The Competition

TypeLonza GroupMedical CompaniesS&P 500
Consensus Rating Score
4.00
2.78
2.53
Consensus RatingStrong BuyModerate BuyModerate Buy
Predicted UpsideN/A15,803.52% Upside10.23% Upside
News Sentiment Rating
Positive News

See Recent LZAGY News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
11/27/2024Redburn Atlantic
5 of 5 stars
J. Clark
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
10/9/2024The Goldman Sachs Group
3 of 5 stars
J. Quigley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
6/23/2024Berenberg Bank
2 of 5 stars
S. Bray
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
2/2/2024Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeHold ➝ Buy
10/9/2023Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOverweight

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 03:03 AM ET.


Should I Buy Lonza Group Stock? LZAGY Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Friday, August 29, 2025. Please send any questions or comments about these Lonza Group pros and cons to contact@marketbeat.com.

Lonza Group
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Lonza Group AG:

  • The current stock price is around $70.64, reflecting a recent increase, which may indicate positive market sentiment towards the company.
  • Short interest in Lonza Group AG has seen significant growth, with a rise of 51.5% recently, suggesting increased investor interest and potential for future price appreciation.
  • The company has a solid financial position, with a quick ratio of 1.04 and a current ratio of 1.52, indicating good liquidity and the ability to meet short-term obligations.
  • Lonza Group AG operates in the pharmaceutical and biotech sectors, which are generally resilient and can offer growth opportunities, especially in the current market environment.
  • The company has a history of increasing dividends, with a recent dividend yield of 15.0%, which can provide a steady income stream for investors.

Lonza Group
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Lonza Group AG for these reasons:

  • Despite the recent increase in stock price, the volatility in the biotech sector can lead to unpredictable price movements, posing risks for investors.
  • The short-interest ratio indicates that there is a significant amount of shares sold short, which could lead to downward pressure on the stock if negative sentiment continues.
  • With a debt-to-equity ratio of 0.45, while manageable, it suggests that the company does carry some debt, which could be a concern in times of rising interest rates.
  • The average trading volume has fluctuated, which may indicate inconsistent investor interest and could affect liquidity for potential buyers.
  • Recent market trends show increased competition in the pharmaceutical and biotech sectors, which could impact Lonza Group AG's market share and profitability.

LZAGY Forecast - Frequently Asked Questions

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Lonza Group in the last twelve months. There are currently 2 strong buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "strong buy" LZAGY shares.

According to analysts, Lonza Group's stock has a predicted downside of -100.00% based on their 12-month stock forecasts.

Analysts like Lonza Group more than other "medical" companies. The consensus rating for Lonza Group is Strong Buy while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how LZAGY compares to other companies.


This page (OTCMKTS:LZAGY) was last updated on 8/30/2025 by MarketBeat.com Staff
From Our Partners